Two more patients in a 10-patient segment of a mid-stage trial testing Gilead Sciences Inc’s experimental hepatitis C drug GS-7977 had the virus return within four weeks of treatment, researchers said on Tuesday. The company, which recently paid nearly $11 billion to acquire the drug and its developer, Pharmasset, said last month that six out of 10 patients with a prior “null response” to standard hepatitis C therapy saw the virus return within four weeks of treatment with a combination of GS-7977 and the antiviral drug ribavirin.
The death of an elderly man from a massive brain hemorrhage after a routine fall suggests that bleeding complications from Boehringer Ingelheim’s Pradaxa blood clot preventer are largely irreversible, according to the Journal of Neurosurgery. U.S. regulators said in December they were evaluating other cases of bleeding associated with the drug, whose chemical name is dabigatran, but advised patients to continue the medicine for now.
As technology has infiltrated all aspects of our society, many patients have witnessed their doctors becoming more tech savvy. This can be seen from the use of electronic tablets upon checking into the office for appointments, along with emergence of electronic filing of prescriptions, and finally with electronic medical records (EMRs) becoming more commonplace in medical offices, emergency departments, and hospitals in general.
Physicians and hospitals must make websites more patient-friendly, study says. Of all the elements that make a good consumer experience, accessibility is especially relevant to health care organizations, said Eric Ford, PhD, a study author and professor of business at the University of North Carolina, Greensboro. The study said accessibility is often lacking on health organization websites.
Express Scripts has developed a set of proprietary computer models that predict, up to a year in advance, which patients are at risk of not following through on their prescribed drug therapy. Now the pharmacy will be able to intervene and help such patients by customizing ways to improve the customer’s adherence to ‘doctor’s orders’. The recently-completed tests show the new computer models to be informative, accurate, and more actionable than any other produced in the industry. Patient behavior in three key treatment classes was used: high blood pressure, diabetes, and high cholesterol.
The economic downturn has kept many cash-strapped patients from seeing their physicians or caused many to delay treatment, research has shown. Studies and reports from doctors provide insight into how patient behavior has been affected by the 2007-09 recession and its slow recovery.
They are older patients with cancer, diabetes, heart disease and other serious chronic conditions. Many have multiple health problems, and their relatives might not be helping with their care. Most have private insurance, are white and female.
They are the costliest 1% of patients in the U.S. Caring for them accounts for more than 20% of what the nation spends on all of its health care. In contrast, the least costly half of all patients are associated with only 3% of total health spending, according to an Agency for Healthcare Research and Quality analysis of spending data from 2008 and 2009 released in January.